Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent
US6916800B2 · kind B2 · utility
50Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2004 |
| Grant date | Jul 12, 2005 |
| Priority date | — |
| Expiry date | Sep 20, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of a matrix metalloproteinase inhibitor and an antineoplastic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.